BioNote, Inc. (KRX:377740)
4,835.00
-5.00 (-0.10%)
At close: Aug 21, 2026
BioNote Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 56,610 | 17,871 | 107,341 | 147,395 | 681,067 | 418,612 |
Short-Term Investments | 295,292 | 307,098 | 298,076 | 252,773 | 672.44 | 70,000 |
Trading Asset Securities | 16,373 | 14,844 | - | - | 39,722 | - |
Cash & Short-Term Investments | 368,274 | 339,813 | 405,416 | 400,168 | 721,461 | 488,612 |
Cash Growth | 4.35% | -16.18% | 1.31% | -44.53% | 47.65% | 139.97% |
Accounts Receivable | 27,656 | 31,460 | 22,006 | 18,174 | 16,374 | 83,961 |
Other Receivables | 5,890 | 5,057 | 3,079 | 6,690 | 1,930 | 117.81 |
Receivables | 33,546 | 36,517 | 25,085 | 24,864 | 18,304 | 84,079 |
Inventory | 31,408 | 27,693 | 25,029 | 30,683 | 79,038 | 64,859 |
Prepaid Expenses | 2,669 | 1,366 | 366.89 | 500.1 | 1,763 | 51.86 |
Other Current Assets | 1,313 | 1,434 | 9,804 | 261.77 | 4,269 | 3,107 |
Total Current Assets | 437,210 | 406,824 | 465,700 | 456,478 | 824,836 | 640,709 |
Property, Plant & Equipment | 84,146 | 84,810 | 92,635 | 89,594 | 97,159 | 98,007 |
Long-Term Investments | 1,087,118 | 1,058,328 | 1,132,268 | 1,035,075 | 827,748 | 743,863 |
Goodwill | 677.68 | 677.68 | 677.68 | 5,512 | 5,512 | 5,512 |
Other Intangible Assets | 2,122 | 2,643 | 3,638 | 4,750 | 1,589 | 354.16 |
Other Long-Term Assets | 834.64 | 539.55 | 854.79 | 491.43 | 157.1 | 422.15 |
Total Assets | 1,614,161 | 1,555,892 | 1,697,157 | 1,592,842 | 1,757,002 | 1,488,867 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5,250 | 4,161 | 2,541 | 3,520 | 3,302 | 5,412 |
Accrued Expenses | 2,152 | 1,736 | 1,979 | 1,591 | 4,689 | 9,547 |
Current Portion of Leases | 1,437 | 1,493 | 1,393 | 1,334 | 468.57 | 295.95 |
Current Income Taxes Payable | 10,447 | 1,322 | 14,207 | 467.56 | 35,157 | 95,913 |
Other Current Liabilities | 4,303 | 4,406 | 3,536 | 3,888 | 5,889 | 7,105 |
Total Current Liabilities | 23,589 | 13,119 | 23,656 | 10,801 | 49,505 | 118,273 |
Long-Term Leases | 1,774 | 2,158 | 2,538 | 3,594 | 893.3 | 473.7 |
Long-Term Deferred Tax Liabilities | 37,665 | 28,936 | 34,817 | 21,652 | 106,300 | 97,517 |
Other Long-Term Liabilities | 477.26 | 432.7 | 374.06 | 219.19 | 151.11 | 99.29 |
Total Liabilities | 63,505 | 44,645 | 61,384 | 36,266 | 156,850 | 216,363 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 51,268 | 51,028 | 51,028 | 51,028 | 50,938 | 46,778 |
Additional Paid-In Capital | 64,397 | 59,744 | 82,744 | 82,744 | 80,997 | 11,877 |
Retained Earnings | 1,366,945 | 1,342,820 | 1,427,616 | 1,392,828 | 1,466,034 | 1,207,900 |
Treasury Stock | -4,867 | -8,109 | -3,108 | - | - | - |
Comprehensive Income & Other | 72,913 | 65,764 | 77,493 | 29,976 | 2,183 | 5,948 |
Shareholders' Equity | 1,550,656 | 1,511,247 | 1,635,773 | 1,556,576 | 1,600,152 | 1,272,504 |
Total Liabilities & Equity | 1,614,161 | 1,555,892 | 1,697,157 | 1,592,842 | 1,757,002 | 1,488,867 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3,211 | 3,651 | 3,931 | 4,928 | 1,362 | 769.65 |
Net Cash (Debt) | 365,063 | 336,162 | 401,485 | 395,240 | 720,100 | 487,842 |
Net Cash Growth | 4.58% | -16.27% | 1.58% | -45.11% | 47.61% | 140.00% |
Net Cash Per Share | 3620.58 | 3321.22 | 3937.74 | 3875.76 | 7637.27 | 5206.96 |
Filing Date Shares Outstanding | 100.8 | 100.43 | 101.36 | 102.06 | 101.88 | 93.56 |
Total Common Shares Outstanding | 100.8 | 100.43 | 101.36 | 102.06 | 101.88 | 93.56 |
Working Capital | 413,621 | 393,705 | 442,045 | 445,677 | 775,331 | 522,435 |
Book Value Per Share | 15383.18 | 15047.11 | 16137.75 | 15252.17 | 15706.85 | 13601.52 |
Tangible Book Value | 1,547,857 | 1,507,926 | 1,631,457 | 1,546,313 | 1,593,051 | 1,266,638 |
Tangible Book Value Per Share | 15355.41 | 15014.05 | 16095.17 | 15151.61 | 15637.15 | 13538.81 |
Land | 38,359 | 38,359 | 38,359 | 38,359 | 14,541 | 14,541 |
Buildings | 22,532 | 28,671 | 28,412 | 28,002 | 25,233 | 25,905 |
Machinery | 15,486 | 37,760 | 32,481 | 31,122 | 38,873 | 30,865 |
Construction In Progress | 334.42 | 293 | 8,980 | 2,002 | 27,821 | 35,303 |